Literature DB >> 8140044

Validation of a variable direction hysteresis minimization pharmacodynamic approach: cardiovascular effects of alfentanil.

N B Modi1, P Veng-Pedersen.   

Abstract

An important goal in therapeutics is the quantitative prediction of drug effects. Although several comprehensive pharmacodynamic models have been proposed, relatively few of these have attempted to assess objectively the application of the models to predict pharmacologic responses. A variable-direction hysteresis minimization approach was proposed recently that allowed the pharmacodynamics of drugs to be modeled using information about drug input. The application and validation of this approach are demonstrated using the pharmacodynamic effect of alfentanil, a short-acting narcotic analgesic agent, in New Zealand White rabbits. A parameter is proposed to assess the ability of the pharmacodynamic model to predict responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140044     DOI: 10.1023/a:1018966232183

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Biophase equilibration times.

Authors:  P Veng-Pedersen; J W Mandema; M Danhof
Journal:  J Pharm Sci       Date:  1991-09       Impact factor: 3.534

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Some cardiovascular and respiratory effects of alfentanil in animals.

Authors:  M Atef; S A Youssef; M A Shalaby; M G el-Sayed; W A Amin
Journal:  Dtsch Tierarztl Wochenschr       Date:  1987-06-09

4.  A system approach to pharmacodynamics. I: Theoretical framework.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

5.  An approach to the modeling of the tolerance mechanism in the drug effect. I: The drug effect as a disturbance of regulations.

Authors:  A Peper; C A Grimbergen; J W Kraal; J H Engelbart
Journal:  J Theor Biol       Date:  1987-08-21       Impact factor: 2.691

6.  An approach to the modeling of the tolerance mechanism in the drug effect. II: On the implications of compensatory regulation.

Authors:  A Peper; C A Grimbergen; J W Kraal; J H Engelbart
Journal:  J Theor Biol       Date:  1988-05-07       Impact factor: 2.691

7.  A note regarding curve fitting with a sum of exponentials.

Authors:  R A Herman; P Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  1988 Nov-Dec       Impact factor: 1.627

8.  Alfentanil's analgesic, respiratory, and cardiovascular actions in relation to dose and plasma concentration in unanesthetized dogs.

Authors:  J O Arndt; B Bednarski; C Parasher
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

9.  Cardiovascular and some respiratory effects of high doses of alfentanil in dogs.

Authors:  J D'Aubioul; W Van Gerven; A Van de Water; R Xhonneux; R S Reneman
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

10.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

View more
  1 in total

1.  A 'bottom-up' approach for endo-PK/PD analysis.

Authors:  S Neelakantan; J A Widness; R L Schmidt; P Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2006-10       Impact factor: 1.627

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.